Trial Profile
An Open-label, Randomized, Two-way Crossover Trial of the Effect of a High-Fat Meal on the Pharmacokinetics of Oral Tosedostat (CHR 2797) in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Sep 2023
Price :
$35
*
At a glance
- Drugs Tosedostat (Primary)
- Indications Unspecified
- Focus Adverse reactions; Pharmacokinetics
- Sponsors CTI BioPharma
- 14 Sep 2023 Status changed from active, no longer recruiting to completed.
- 19 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Jul 2012 New trial record